We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Chagas Disease, Neurocysticercosis Now Eligible for FDA Priority Review Voucher
Chagas Disease, Neurocysticercosis Now Eligible for FDA Priority Review Voucher
The FDA has added Chagas disease and neurocysticercosis to the list of treatments for tropical diseases eligible for priority review vouchers, bringing the number to 19.